Poland· PL-100421566
Rosuvastatin/Amlodipine Teva
A rosuvastatin und amlodipin product containing rosuvastatinum + amlodipinum, registered in Poland by Teva B.V.. The same ATC class is registered in 5 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Rosuvastatin und amlodipin is registered in 5 of 19 countries.
Countries holding a registration under ATC C10BX09 (rosuvastatin und amlodipin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Rosuvastatin und amlodipin · ATC C10BX09
5 / 19 countries
- Belgiumprice
- Finlandprice
- Ireland
- Italyprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Rosuvastatinum + Amlodipinum
- Manufacturer
- Teva B.V.
- Country
- Poland (PL)
- ATC code
- C10BX09
- ATC class
- Rosuvastatin und Amlodipin
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909991465773
- gtin05909991465780
- gtin05909991465797
- gtin05909991465803
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Rosuvastatin und amlodipin in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- ItalyCOAREDAMSCHARPER S.P.A.
- SpainROSUVASTATINA/AMLODIPINO ARISTO 10 MG/10 MG CAPSULAS DURASAristo Pharma Gmbh
- FinlandRosudapinKRKA d.d. Novo mesto
- GermanyRosuamlo ApontisAdamed Pharma S.A.
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Bulgaria · Тинтарос Ам
- Germany · Rosuamlo Apontis, Rosulod
- Spain · Rosuvastatina/Amlodipino Aristo
- Italy · Coaredam, Rosulod
- Portugal · Asutam
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b5a77b78-6b92-4a9b-b03d-68eef80de9a6 GET /v1/drugs/b5a77b78-6b92-4a9b-b03d-68eef80de9a6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki twarde",
"source": "urpl",
"strength": "10 mg + 10 mg",
"packaging": "05909991465773 ¦ Rp ¦ 141931\n100 kaps.\n05909991465780 ¦ Rp ¦ 141932\n30 kaps.\n05909991465797 ¦ Rp ¦ 141933\n10 kaps.\n05909991465803 ¦ Rp ¦ 141934\n28 kaps.",
"substance": "Rosuvastatinum 10 mg + Amlodipinum 10 mg",
"common_name": "Rosuvastatinum + Amlodipinum",
"pl_product_id": "100421566",
"pozwolenie_nr": "26644",
"auth_procedure": "DCP",
"authorisation_validity": "2026-09-30"
}See everything about rosuvastatin und amlodipin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.